Literature DB >> 29436581

The PI3K/Akt/FOXO3a pathway regulates regeneration following spinal cord injury in adult rats through TNF-α and p27kip1 expression.

Honghui Lu1, Li-Hai Zhang2, Lin Yang3, Pei-Fu Tang2.   

Abstract

The aim of the present study was to elucidate the expression and role of the phosphatidylinositol 3‑kinase (PI3K)/Akt/forkhead box O3 (FOXO3a) pathway in the regeneration of the spinal cord following spinal cord injury (SCI), and its regulatory effect on tumor necrosis factor (TNF)-α and cyclin-dependent kinase inhibitor 1B (p27kip1) expression. Firstly, in a Sprague-Dawley rat model of SCI, western blot analysis revealed that the protein levels of PI3K, phosphorylated Akt and FOXO3a were markedly inhibited compared with those in the sham control group. In vitro experiments were also conducted, in which primary dissociated cultures of rat dorsal spinal cord cells were induced with lipopolysaccharide (LPS; 4 µg/ml). The downregulation of PI3K using LY294002 markedly suppressed cell viability, reduced the protein levels of FOXO3a and p27kip1, and increased TNF-α protein production in the LPS-induced spinal cord cells. In addition, when the LPS-induced spinal cord cells were infected with FOXO3a adenoviral vectors, the overexpression of FOXO3 markedly promoted cell proliferation, activated p27kip1 protein levels and inhibited TNF-α protein production in the spinal cord cells. These results suggest that the PI3K/Akt/FOXO3a pathway regulates regeneration following SCI in adult rats via its modulatory effects on TNF-α and p27kip1 expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29436581     DOI: 10.3892/ijmm.2018.3459

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

Review 1.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

2.  CD28 Deficiency Ameliorates Blast Exposure-Induced Lung Inflammation, Oxidative Stress, Apoptosis, and T Cell Accumulation in the Lungs via the PI3K/Akt/FoxO1 Signaling Pathway.

Authors:  Yunen Liu; Changci Tong; Ying Xu; Peifang Cong; Ying Liu; Lin Shi; Xiuyun Shi; Yan Zhao; Guangyuan Bi; Hongxu Jin; Mingxiao Hou
Journal:  Oxid Med Cell Longev       Date:  2019-09-02       Impact factor: 6.543

3.  Downregulation of TAF9B by miR-7-5p Inhibits the Progression of Osteosarcoma.

Authors:  Wanli Gu; Peng Chen; Peng Ren; Yanhai Wang; Xiaobing Li; Mingzhi Gong
Journal:  Onco Targets Ther       Date:  2021-04-30       Impact factor: 4.147

4.  Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury.

Authors:  Shaoshuo Li; Yang Shao; Hao Chen; Jianwei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-27       Impact factor: 2.629

5.  Drug Discovery in Spinal Cord Injury With Ankylosing Spondylitis Identified by Text Mining and Biomedical Databases.

Authors:  Chenfeng Wang; Hongdao Ma; Weiqing Wu; Xuhua Lu
Journal:  Front Genet       Date:  2022-02-25       Impact factor: 4.599

Review 6.  PPARβ/δ: Linking Metabolism to Regeneration.

Authors:  Ajit Magadum; Felix B Engel
Journal:  Int J Mol Sci       Date:  2018-07-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.